QQ客服 官方微博 反馈留言

	Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer
	Yang, Jin-ji; Zhou, Jianying; Wang, Jie; An, Tongtong; Yang, Lei; Liu, Zhe; Zhou, Xiangdong; Chen, Mo; Hua, Ye; Su, Weiguo
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2018
卷号	36期号:12
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3534183
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Yang, Jin-ji,Zhou, Jianying,Wang, Jie,et al. Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer[J]. JOURNAL OF CLINICAL ONCOLOGY,2018,36(12).
APA	Yang, Jin-ji.,Zhou, Jianying.,Wang, Jie.,An, Tongtong.,Yang, Lei.,...&Liu, Xiaoqing.(2018).Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer.JOURNAL OF CLINICAL ONCOLOGY,36(12).
MLA	Yang, Jin-ji,et al."Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer".JOURNAL OF CLINICAL ONCOLOGY 36.12(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。